創傷護理中的生物製藥療法：技術與全球市場

全球生物製藥創傷護理產品市場預計將從 2025 年的 70 億美元成長到 2030 年底的 108 億美元，在 2025 年至 2030 年的預測期內，複合年成長率將達到 9.1%。

預計北美創傷護理生物製藥市場將從 2025 年的 31 億美元成長到 2030 年底的 47 億美元，在 2025 年至 2030 年的預測期內，複合年成長率將達到 9%。

歐洲創傷護理生物製藥市場預計將從 2025 年的 22 億美元成長到 2030 年底的 34 億美元，在 2025 年至 2030 年的預測期內，複合年成長率將達到 8.7%。

調查範圍

這份「全球創傷護理生物製藥市場報告」提供了市場概覽和趨勢分析。報告包含基準年（2024年）和預測期間（2025年至2030年）的全球銷售額預估值（百萬美元）。市場區隔依據產品類型、應用、最終用戶和地區。本研究涵蓋的地區包括北美、歐洲、亞太地區和世界其他地區（RoW），並重點關注各地區的主要國家。

本報告重點在於影響市場和供應商格局的關鍵促進因素和挑戰，並探討與市場相關的新興技術。報告最後分析了競爭格局，包括對全球創傷護理生物製藥市場主要參與者的排名。此外，報告也特別闢出章節介紹各公司概況，涵蓋公司概況、關鍵財務指標、產品系列和近期發展等詳細資訊。

報告內容

• 數據表 78 和附加表 61
• 全球創傷護理生物製藥及相關技術市場概覽與分析
• 全球趨勢分析，包括 2022 年至 2025 年的歷史數據以及到 2030 年的複合年成長率預測。
• 全球市場規模、估算和收入預測，以及按產品類型、應用、最終用戶和地區分類的市場佔有率分析。
• 有關市場動態、技術進步、法規、前景和宏觀經濟變數的影響的事實和數據。
• 基於波特五力模型和全球供應鏈分析的見解。
• 專利綜述，重點介紹已註冊和已公佈的主要專利
• 產業結構分析，包括公司市場佔有率和排名、產品佈局、策略舉措、併購活動和創業融資前景。
• 概述永續發展趨勢和ESG進展。重點關注消費者意識以及大型企業對ESG風險的評估和實施。
• 全球領導者的簡介，包括 Convatec Group PLC、Integra LifeSciences Corp.、MIMEDX Group Inc. 和 Organogenesis Inc.。

目錄

第1章摘要整理

第2章 市場概覽

• 創傷護理史
• 技術背景
• 傷口類型
• 創傷治療過程
• 止血
• 發炎
• 普及
• 成熟還是重塑？
• 細胞外基質的結構及其在皮膚創傷治療中的重要性
• 用於創傷護理的生物療法
• 本土種植
• 同種異體移植
• 不同物種/不同來源
• 宏觀經濟因素分析
• PESTLE分析
• 美國關稅法對創傷護理生技藥品市場的影響
• 波特五力分析

第3章 市場動態

• 市場促進因素
• 老年人口增加
• 糖尿病和目標疾病盛行率增加
• 燒傷發生率增加
• 創傷護理生物製藥的創新
• 市場限制因素
• 高成本和熟練勞動力短缺
• 不利的贖回方案
• 複雜的法律規範
• 市場機遇
• 擴大創傷護理生物製藥市場的產業合作
• 新興市場的成長機遇

第4章 監管情勢

• FDA監管審查和批准流程
• 上市前批准（PMA）
• 510(k) 批准
• 生技藥品核准申請
• 人源細胞、組織及細胞/組織衍生產品（HCT/Ps）
• 適用範圍和報銷方式
• 醫療保險覆蓋範圍
• 醫療補助
• 私人保險公司

第5章：新興科技與新趨勢

• 概述
• 智慧敷料和生物活性奈米材料
• 3D生物列印
• 人工智慧（AI）在創傷護理生物製藥的應用

第6章 市場區隔分析

• 細分市場
• 市場趨勢：依產品類型分類
• 細胞/組織衍生產品（CTP）/皮膚替代品
• 無細胞CTP
• 細胞衍生CTP
• 生物基皮膚替代品
• 生物工程皮膚替代品
• 外用製劑
• 角蛋白
• 酵素清創劑
• 市場趨勢：按應用領域分類
• 慢性傷口
• 急性傷口
• 市場趨勢：依最終用戶分類
• 門診手術中心（ASC）
• 醫院
• 燒傷治療中心和傷口診所
• 按地區分類
• 市場趨勢：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區（RoW）

第7章 競爭情勢

• 2024年創傷護理生物製藥市場領導企業排名。
• 按產品類型分類的主要公司
• 同種異體移植
• 無細胞動物性組織製品/異種移植
• 戰略分析

第8章附錄

• 調查方法
• 簡稱
• 參考
• 公司簡介
• ABBVIE INC.
• AROA BIOSURGERY LTD.
• BIOTISSUE
• BIOVENTUS
• CELLUTION BIOLOGICS INC.
• CONVATEC GROUP PLC
• ELUTIA
• FIBROHEAL
• INTEGRA LIFESCIENCES CORP.
• JOHNSON & JOHNSON
• MIMEDX GROUP INC.
• ORGANOGENESIS INC.
• SKYE BIOLOGICS HOLDINGS LLC.
• SMITH+NEPHEW
• STRYKER
• ZIMMER BIOMET

The global market for wound care biologics is expected to grow from $7 billion in 2025 and is projected to reach $10.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030.

The North American market for wound care biologics is expected to grow from $3.1 billion in 2025 and is projected to reach $4.7 billion by the end of 2030, at a CAGR of 9% during the forecast period of 2025 to 2030.

The European market for wound care biologics is expected to grow from $2.2 billion in 2025 and is projected to reach $3.4 billion by the end of 2030, at a CAGR of 8.7% during the forecast period of 2025 to 2030.

Report Scope

The global wound care biologics report provides an overview and analyzes market trends. The report includes global revenue ($ million) for the base year data (2024) and estimated data for the forecast period (2025 through 2030). The market is segmented by product type, application, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, and the rest of the World (RoW), with a focus on major countries in each region.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, including rankings of key companies in the global wound care biologics market. It also features a dedicated section of company profiles that covers details such as overview, key financials, product portfolio, and recent developments of key companies.

Report Includes

• 78 data tables and 61 additional tables
• Overview and an analysis of the global market for wound care biologics and related technologies
• Analyses of the global market trends, with historic data from 2022 to 2025, and projections of CAGRs through 2030
• Estimates of the market size and revenue prospects for the global market, accompanied by a market share analysis by product type, application, end user, and region
• Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Profiles of the leading global companies, including Convatec Group PLC., Integra LifeSciences Corp., MIMEDX Group Inc., and Organogenesis Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• History of Wound Care
• Technology Background
• Types of Wounds
• Wound Healing Process
• Hemostasis
• Inflammation
• Proliferation
• Maturation or Remodeling
• ECM Composition and Its Importance in Skin Wound Healing
• Biologic Therapies for Wound Care
• Autologous
• Allogeneic
• Heterologous/Xenogenic
• Macroeconomic Factors Analysis
• PESTEL Analysis
• Impact of U.S. Tariff Laws on the Wound Care Biologics Market
• Porter's Five Forces Analysis
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate to High)
• Bargaining Power of Buyers (High)
• Threat of Substitutes (High)
• Competition in the Industry (High)

Chapter 3 Market Dynamics

• Market Drivers
• Growing Geriatric Population
• Increasing Prevalence of Diabetes and Target Conditions
• Increasing Incidence of Burn Injuries
• Innovations in Wound Care Biologics
• Market Restraints
• High Cost and Lack of Skilled Workforce
• Unfavorable Reimbursement Scenario
• Complex Regulatory Framework
• Market Opportunities
• Growing Industry Collaborations in Wound Care Biologics Market
• Growth Opportunities in Emerging Markets

Chapter 4 Regulatory Landscape

• FDA Regulatory Review and Approval Process
• Premarket Approval (PMA)
• 510(k) Clearance
• Biologics License Application
• Human Cells, Tissues, and Cellular and Tissue-based Products (HCT/Ps)
• Coverage and Reimbursement
• Medicare Coverage
• Medicaid
• Private Payers

Chapter 5 Emerging Technologies and New Developments

• Overview
• Smart Dressings and Bioactive Nanomaterials
• 3D Bioprinting
• Artificial Intelligence (AI) in Wound Care Biologics

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Product Type
• Key Takeaways
• Cellular and Tissue-Based Products (CTPs)/Skin Substitutes
• Acellular CTPs
• Cellular CTPs
• Biologic Skin Substitute
• Bioengineered Skin Substitutes
• Topical Agents
• Keratin Proteins
• Enzymatic Debridement Agents
• Market Breakdown by Application
• Key Takeaways
• Chronic Wounds
• Acute Wounds
• Market Breakdown by End User
• Key Takeaways
• Ambulatory Surgery Centers (ASCs)
• Hospitals
• Burn Care Centers and Wound Clinics
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Key Takeaways
• Top Companies Ranking in Wound Care Biologics Market, 2024
• Key Companies by Product Type
• Allografts
• Acellular Animal-Derived Tissue-Based Products/Xenografts
• Strategic Analysis

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• ABBVIE INC.
• AROA BIOSURGERY LTD.
• BIOTISSUE
• BIOVENTUS
• CELLUTION BIOLOGICS INC.
• CONVATEC GROUP PLC
• ELUTIA
• FIBROHEAL
• INTEGRA LIFESCIENCES CORP.
• JOHNSON & JOHNSON
• MIMEDX GROUP INC.
• ORGANOGENESIS INC.
• SKYE BIOLOGICS HOLDINGS LLC.
• SMITH + NEPHEW
• STRYKER
• ZIMMER BIOMET

List of Tables

• Summary Table : Global Market for Wound Care Biologics, by Region, Through 2030
• Table 1 : ECM Components and Their Role in Wound Healing
• Table 2 : Number and Distribution of Persons Age 60+, by Region, 2019 and 2050
• Table 3 : Global Prevalence of Diabetes, by Population Segment, Through 2045
• Table 4 : Recent Industry Collaborations in Wound Care Biologics Market, 2024-2025
• Table 5 : Emerging Nanotherapeutic Approaches for Wound Healing Applications
• Table 6 : Emerging Bioprinting Methods for Wound Healing Applications
• Table 7 : Global Market for Wound Care Biologics, by Product Type, Through 2030
• Table 8 : Global Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
• Table 9 : Global Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
• Table 10 : Global Market for Wound Care Biologics for Acellular CTPs, by Region, Through 2030
• Table 11 : Global Market for Wound Care Biologics for Cellular CTPs, by Region, Through 2030
• Table 12 : Global Market for Wound Care Biologics for Biologic Skin Substitutes, by Region, Through 2030
• Table 13 : Global Market for Wound Care Biologics for Biologic Skin Substitute, by Tissue Source, Through 2030
• Table 14 : Placental Allograft Products
• Table 15 : Global Market for Wound Care Biologics for Allografts, by Region, Through 2030
• Table 16 : Acellular Animal-Derived Tissue-Based Products/Xenografts
• Table 17 : Global Market for Wound Care Biologics for Xenografts, by Region, Through 2030
• Table 18 : Global Market for Wound Care Biologics for Bioengineered Skin Substitute, by Composition, Through 2030
• Table 19 : Global Market for Wound Care Biologics for Bioengineered Skin Substitute, by Region, Through 2030
• Table 20 : Human Cellular Bioengineered Skin Substitutes
• Table 21 : Global Market for Wound Care Biologics for Cellular Bioengineered Skin Substitute, by Region, Through 2030
• Table 22 : Biosynthetic Skin Substitutes
• Table 23 : Global Market for Wound Care Biologics for Acellular Bioengineered Skin Substitute, by Region, Through 2030
• Table 24 : Global Market for Wound Care Biologics for Topical Agents, by Region, Through 2030
• Table 25 : Examples of Commercially Available Topical Agents
• Table 26 : Global Market for Wound Care Biologics, by Application, Through 2030
• Table 27 : Global Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
• Table 28 : Global Market for Wound Care Biologics for Chronic Wounds, by Region, Through 2030
• Table 29 : Global Market for Wound Care Biologics for Venous Ulcers, by Region, Through 2030
• Table 30 : Global Market for Wound Care Biologics for Diabetic Foot Ulcers, by Region, Through 2030
• Table 31 : FDA-Approved Wound Care Biologics for DFU Treatment
• Table 32 : Wound Care Biologics in Clinical Trials for DFU Treatment
• Table 33 : Global Market for Wound Care Biologics for Pressure Ulcers, by Region, Through 2030
• Table 34 : Global Market for Wound Care Biologics for Arterial and Other Ulcers, by Region, Through 2030
• Table 35 : Global Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
• Table 36 : Global Market for Wound Care Biologics for Acute Wounds, by Region, Through 2030
• Table 37 : Global Market for Wound Care Biologics for Surgical and Traumatic Wounds, by Region, Through 2030
• Table 38 : Burn Classifications
• Table 39 : Global Market for Wound Care Biologics for Burns, by Region, Through 2030
• Table 40 : Global Market for Wound Care Biologics, by End User, Through 2030
• Table 41 : Global Market for Wound Care Biologics for Ambulatory Surgery Centers, by Region, Through 2030
• Table 42 : Global Market for Wound Care Biologics for Hospitals, by Region, Through 2030
• Table 43 : Global Market for Wound Care Biologics for Burn Care Centers and Wound Clinics, by Region, Through 2030
• Table 44 : Global Market for Wound Care Biologics, by Region, Through 2030
• Table 45 : North American Market for Wound Care Biologics, by Product Type, Through 2030
• Table 46 : North American Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
• Table 47 : North American Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
• Table 48 : North American Market for Wound Care Biologics, by Application, Through 2030
• Table 49 : North American Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
• Table 50 : North American Market for Wound Care Biologics for Acute Wounds, by Type Through 2030
• Table 51 : North American Market for Wound Care Biologics, by End User, Through 2030
• Table 52 : North American Market for Wound Care Biologics, by Country, Through 2030
• Table 53 : European Market for Wound Care Biologics, by Product Type, Through 2030
• Table 54 : European Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
• Table 55 : European Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
• Table 56 : European Market for Wound Care Biologics, by Application, Through 2030
• Table 57 : European Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
• Table 58 : European Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
• Table 59 : European Market for Wound Care Biologics, by End User, Through 2030
• Table 60 : European Market for Wound Care Biologics, by Country, Through 2030
• Table 61 : Asia-Pacific Market for Wound Care Biologics, by Product Type, Through 2030
• Table 62 : Asia-Pacific Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
• Table 63 : Asia-Pacific Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
• Table 64 : Asia-Pacific Market for Wound Care Biologics, by Application, Through 2030
• Table 65 : Asia-Pacific Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
• Table 66 : Asia-Pacific Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
• Table 67 : Asia-Pacific Market for Wound Care Biologics, by End User, Through 2030
• Table 68 : Asia-Pacific Market for Wound Care Biologics, by Country, Through 2030
• Table 69 : Rest of the World Market for Wound Care Biologics, by Product Type, Through 2030
• Table 70 : Rest of the World Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
• Table 71 : Rest of the World Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
• Table 72 : Rest of the World Market for Wound Care Biologics, by Application, Through 2030
• Table 73 : Rest of the World Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
• Table 74 : Rest of the World Market for Wound Care Biologics for Acute Wounds, by TypeThrough 2030
• Table 75 : Rest of the World Market for Wound Care Biologics, by End User, Through 2030
• Table 76 : Rest of the World Market for Wound Care Biologics, by Sub-Region, Through 2030
• Table 77 : Top Companies Ranking, 2024
• Table 78 : Key Wound Care Biologics Manufacturers' Offerings
• Table 79 : Leading Companies in Allografts
• Table 80 : Key Companies' Allograft Offerings, by Product Type
• Table 81 : Leading Acellular Animal-Derived Tissue-Based Products/Xenografts
• Table 82 : Recent Developments in the Wound Care Biologics Market, 2023-2025
• Table 83 : Abbreviations Used in This Report
• Table 84 : AbbVie Inc.: Company Snapshot
• Table 85 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
• Table 86 : AbbVie Inc.: Product Portfolio
• Table 87 : AbbVie Inc.: News/Key Developments, 2023-2025
• Table 88 : Aroa Biosurgery Ltd.: Company Snapshot
• Table 89 : Aroa Biosurgery Ltd.: Financial Performance, FY 2023 and 2024
• Table 90 : Aroa Biosurgery Ltd.: Product Portfolio
• Table 91 : Aroa Biosurgery Ltd.: News/Key Developments, 2023-2024
• Table 92 : BioTissue: Company Snapshot
• Table 93 : BioTissue: Product Portfolio
• Table 94 : BioTissue: News/Key Developments, 2023-2025
• Table 95 : Bioventus: Company Snapshot
• Table 96 : Bioventus: Financial Performance, FY 2023 and 2024
• Table 97 : Bioventus: Product Portfolio
• Table 98 : Cellution Biologics Inc.: Company Snapshot
• Table 99 : Cellution Biologics Inc.: Product Portfolio
• Table 100 : Cellution Biologics Inc.: News/Key Developments, 2024-2025
• Table 101 : Convatec Group PLC: Company Snapshot
• Table 102 : Convatec Group PLC: Financial Performance, FY 2023 and 2024
• Table 103 : Convatec Group PLC: Product Portfolio
• Table 104 : Convatec Group PLC: News/Key Developments, 2025
• Table 105 : Elutia: Company Snapshot
• Table 106 : Elutia: Financial Performance, FY 2023 and 2024
• Table 107 : Elutia: Product Portfolio
• Table 108 : Elutia: News/Key Developments, 2024-2025
• Table 109 : Fibroheal: Company Snapshot
• Table 110 : Fibroheal: Product Portfolio
• Table 111 : Fibroheal: News/Key Developments, 2024
• Table 112 : Integra LifeSciences Corp.: Company Snapshot
• Table 113 : Integra LifeSciences Corp.: Financial Performance, FY 2023 and 2024
• Table 114 : Integra LifeSciences Corp.: Product Portfolio
• Table 115 : Integra LifeSciences Corp.: News/Key Developments, 2024
• Table 116 : Johnson & Johnson: Company Snapshot
• Table 117 : Johnson & Johnson: Financial Performance, FY 2023 and 2024
• Table 118 : Johnson & Johnson: Product Portfolio
• Table 119 : MIMEDX Group Inc.: Company Snapshot
• Table 120 : MIMEDX Group Inc.: Financial Performance, FY 2023 and 2024
• Table 121 : MIMEDX Group Inc.: Product Portfolio
• Table 122 : MIMEDX Group Inc.: News/Key Developments, 2022-2024
• Table 123 : Organogenesis Inc.: Company Snapshot
• Table 124 : Organogenesis Inc.: Financial Performance, FY 2023 and 2024
• Table 125 : Organogenesis Inc.: Product Portfolio
• Table 126 : Skye Biologics Holdings LLC.: Company Snapshot
• Table 127 : Skye Biologics Holdings LLC.: Product Portfolio
• Table 128 : Smith+Nephew: Company Snapshot
• Table 129 : Smith+Nephew: Financial Performance, FY 2023 and 2024
• Table 130 : Smith+Nephew: Product Portfolio
• Table 131 : Smith+Nephew: News/Key Developments, 2023-2024
• Table 132 : Stryker: Company Snapshot
• Table 133 : Stryker: Financial Performance, FY 2023 and 2024
• Table 134 : Stryker: Product Portfolio
• Table 135 : Stryker: News/Key Developments, 2025
• Table 136 : Zimmer Biomet: Company Snapshot
• Table 137 : Zimmer Biomet: Financial Performance, FY 2023 and 2024
• Table 138 : Zimmer Biomet: Product Portfolio

List of Figures

• Summary Figure : Summary Figure: Global Market Shares of Wound Care Biologics, by Region, 2024
• Figure 1 : Stages of Wound Healing
• Figure 2 : PESTEL Analysis: Wound Care Biologics Market
• Figure 3 : Porter's Five Forces Analysis of the Wound Care Biologics Market
• Figure 4 : Snapshot of the Market Dynamics for Wound Care Biologics
• Figure 5 : Estimated Number of People Aged 20 to 79 with Diabetes, Globally, 2000-2024
• Figure 6 : Emerging Technologies in Wound Care Biologics Market
• Figure 7 : Global Market Shares of Wound Care Biologics, by Product Type, 2024
• Figure 8 : Global Market Shares of Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, 2024
• Figure 9 : Global Market Shares of Wound Care Biologics for Cellular and Tissue-Based Products, by Material, 2024
• Figure 10 : Global Market Shares of Biologic Skin Substitute, by Tissue Source, 2024
• Figure 11 : Global Market Shares of Wound Care Biologics for Bioengineered Skin Substitute, by Composition, 2024
• Figure 12 : Global Market Shares of Wound Care Biologics, by Application, 2024
• Figure 13 : Global Market Shares of Chronic Wounds, by Type, 2024
• Figure 14 : Global Market Shares of Acute Wounds, by Type, 2024
• Figure 15 : Global Market Shares of Wound Care Biologics, by End User, 2024
• Figure 16 : Global Market Shares of Wound Care Biologics, by Region, 2024
• Figure 17 : North American Market Shares of Wound Care Biologics, by Country, 2024
• Figure 18 : U.S. Elderly Population (65 and Older), 2010-2050
• Figure 19 : European Market Shares of Wound Care Biologics, by Country, 2024
• Figure 20 : Asia-Pacific Market Shares of Wound Care Biologics, by Country, 2024
• Figure 21 : Rest of the World Market Shares of Wound Care Biologics, by Sub-Region, 2024
• Figure 22 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 23 : AbbVie Inc.: Revenue Shares, by Region/Country, FY 2024
• Figure 24 : Aroa Biosurgery Ltd.: Revenue Shares, by Business Unit, FY 2024
• Figure 25 : Aroa Biosurgery Ltd.: Revenue Shares, by Region/Country, FY 2024
• Figure 26 : Bioventus: Revenue Shares, by Region, FY 2024
• Figure 27 : Convatec Group PLC: Revenue Shares, by Business Unit, FY 2024
• Figure 28 : Convatec Group PLC: Revenue Shares, by Region, FY 2024
• Figure 29 : Elutia: Revenue Shares, by Business Unit, FY 2024
• Figure 30 : Integra LifeSciences Corp.: Revenue Shares, by Business Unit, FY 2024
• Figure 31 : Integra LifeSciences Corp.: Revenue Shares, by Region, FY 2024
• Figure 32 : Johnson & Johnson: Revenue Shares, by Business Segment, FY 2024
• Figure 33 : Johnson & Johnson: Revenue Shares, by Country/Region, FY 2024
• Figure 34 : MIMEDX Group Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 35 : Organogenesis Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 36 : Smith+Nephew: Revenue Shares, by Business Unit, FY 2024
• Figure 37 : Smith+Nephew: Revenue Shares, by Country/Region, FY 2024
• Figure 38 : Stryker: Revenue Shares, by Business Unit, FY 2024
• Figure 39 : Stryker: Revenue Shares, by Country/Region, FY 2024
• Figure 40 : Zimmer Biomet: Revenue Shares, by Business Unit, FY 2024
• Figure 41 : Zimmer Biomet: Revenue Shares, by Country/Region, FY 2024